Opaganib 'completely inhibited' replication of the SARS-CoV-2 virus in in-vitro model of human bronchial tissue, Israeli firm says; study still to be submitted for peer review

Compassionate and experimental use of Opaganib in Israel has had 'encouraging results'; by inhibiting enzyme, drug helps reduce inflammation levels and halts virus from replicating

Gilead Sciences says government medical agency to soon present results of trial testing remdesivir, which has been used at least once in Israel to treat virus

Pair treated with Opaganib, from biopharmaceutical firm RedHill, showed progress within a few days of starting treatment, company says

Firm's Opaganib drug administered to coronavirus patient for the first time in Israel, gets approval from Italian authorities under compassionate use guidelines

Firm's Talicia pill combats H. pylori bacteria, a major carcinogen which affects some 2 million US adults

Israeli firm plans to start selling the pill in the US in first quarter 2020, targeting more than 2 million patients treated for H. pylori infection annually; shares surge

If the Talicia drug to combat H. pylori bacterial infection gets approved, commercial launch is planned for the fourth quarter of 2019, Israeli firm says